Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

WHO grade II and III gliomas: State of the art management

Survivorship and delayed effects

Date

28 Sep 2019

Session

WHO grade II and III gliomas: State of the art management

Topics

Tumour Site

Central Nervous System Malignancies

Presenters

Anna Sophie Berghoff

Authors

A.S. Berghoff

Author affiliations

  • Department Of Medicine 1, Medizinische Universitaet Wien (Medical University of Vienna), 1090 - Vienna/AT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Presentation of case/condition

Presenter: Anna Sophie Berghoff

Session: WHO grade II and III gliomas: State of the art management

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.